GGrantIndex
← Leaderboards

Hongbing Wang

University Of Maryland Baltimore

$9,710,389
Attributed
$11,664,014
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,864,152 · 6
FDA$799,862 · 1

By mechanism

R01$10,458,589 · 5
U01$799,862 · 1
R21$405,563 · 1

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Others in their field

Top investigators on “Liver

Research focus

LiverHepaticMediatingHepatocyteMolecularIn VitroIn VivoPlayXenobioticsGenesPharmaceutical PreparationsCell LineConstitutive Androstane ReceptorBaseCyp2b6 GeneEnzymesMetabolicAffectMetabolismCyp3a4 GeneDrug MetabolismGenetic TranscriptionTranscription FactorNovel Strategies

Grant awards (31)

Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification$2,840,768
R01 · FY2025 · CA · contact PI
Comprehensive assessment of the diastereomer composition of LEQVIO (Inclisiran) to determine how chemical synthesis impacts biological activity$499,887
U01 · FY2025 · FD
Novel noncanonical actions of CAR in human Liver$398,021
R01 · FY2025 · CA · contact PI
Novel noncanonical actions of CAR in human Liver$382,378
R01 · FY2024 · CA · contact PI
Comprehensive assessment of the diastereomer composition of LEQVIO (Inclisiran) to determine how chemical synthesis impacts biological activity$299,975
U01 · FY2024 · FD
Novel noncanonical actions of CAR in human Liver$392,612
R01 · FY2023 · CA · contact PI
Novel noncanonical actions of CAR in human Liver$390,827
R01 · FY2022 · CA · contact PI
Novel noncanonical actions of CAR in human Liver$390,624
R01 · FY2021 · CA · contact PI
Function and Regulation of SLC13A5 in the Liver$297,413
R01 · FY2021 · GM · contact PI
Human CYP2B6 in alcohol metabolism and alcoholic liver injury$183,469
R21 · FY2021 · AA · contact PI
Function and Regulation of SLC13A5 in the Liver$297,413
R01 · FY2020 · GM · contact PI
Human CYP2B6 in alcohol metabolism and alcoholic liver injury$222,094
R21 · FY2020 · AA · contact PI
Function and Regulation of SLC13A5 in the Liver$132,050
R01 · FY2020 · GM · contact PI
Function and Regulation of SLC13A5 in the Liver$297,413
R01 · FY2019 · GM · contact PI
Function and Regulation of SLC13A5 in the Liver$297,413
R01 · FY2018 · GM · contact PI
Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy$291,650
R01 · FY2016 · GM · contact PI
Regulation of CYP2B6 in Human Liver$333,863
R01 · FY2015 · DK · contact PI
Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy$291,650
R01 · FY2015 · GM · contact PI
Regulation of CYP2B6 in Human Liver$333,863
R01 · FY2014 · DK · contact PI
Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy$291,650
R01 · FY2014 · GM · contact PI
Regulation of CYP2B6 in Human Liver$322,178
R01 · FY2013 · DK · contact PI
Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy$291,650
R01 · FY2013 · GM · contact PI
Regulation of CYP2B6 in Human Liver$333,863
R01 · FY2012 · DK · contact PI
Regulation of CYP2B6 in Human Liver$383,750
R01 · FY2011 · DK · contact PI
Regulation of CYP2B6 in Human LIver$295,353
R01 · FY2010 · DK · contact PI
Regulation of CYP2B6 in Human LIver$298,337
R01 · FY2009 · DK · contact PI
Regulation of CYP2B6 in Human LIver$298,337
R01 · FY2008 · DK · contact PI
Regulation of CYP2B6 in Human LIver$296,471
R01 · FY2007 · DK · contact PI
Regulation of CYP2B6 in Human Liver$127,784
R01 · FY2005 · DK
Regulation of CYP2B6 in Human Liver$115,884
R01 · FY2005 · DK
Regulation of CYP2B6 in Human Liver$35,374
R01 · FY2005 · DK